These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6403102)

  • 41. Erythrocyte and monocyte insulin binding in man: a comparative analysis in normal and disease states.
    Dons RF; Ryan J; Gorden P; Wachslicht-Rodbard H
    Diabetes; 1981 Nov; 30(11):896-902. PubMed ID: 7028544
    [No Abstract]   [Full Text] [Related]  

  • 42. Metformin revisited: its actions and indications for use.
    Bailey CJ
    Diabet Med; 1988; 5(4):315-20. PubMed ID: 2968877
    [No Abstract]   [Full Text] [Related]  

  • 43. Glycosylated hemoglobin and its temporal relationship to plasma glucose in non-insulin dependent (type 2) diabetes mellitus.
    Borsey DQ; Fraser DM; Gray RS; Elton RA; Smith AF; Clarke BF
    Metabolism; 1982 Apr; 31(4):362-5. PubMed ID: 7078419
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insulin receptor binding to blood cells: an outdated concept for clinical studies on insulin resistance?
    Müller MJ
    Klin Wochenschr; 1987 Oct; 65(20):949-54. PubMed ID: 3323643
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diabetic control on once- and twice-daily insulin injections.
    Boucher BJ; Walton C; Welch SG; Barnett D; Yudkin JS; Monson JP
    Diabetologia; 1980 Nov; 19(5):485. PubMed ID: 7004970
    [No Abstract]   [Full Text] [Related]  

  • 46. The hypoglycaemic action of metformin.
    Frayn KN; Adnitt PI; Turner P
    Postgrad Med J; 1971 Dec; 47(554):777-80. PubMed ID: 5138746
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of metformin on insulin receptor binding and diabetic control.
    Khokher NA; Woods RJ; Taylor AM; Dandona P
    Br Med J (Clin Res Ed); 1983 May; 286(6377):1576. PubMed ID: 6405894
    [No Abstract]   [Full Text] [Related]  

  • 48. Trypsin-induced alterations of insulin binding, microfilament organization and cell shape in fibroblastic cultures from non-diabetic and diabetic mice.
    Raizada MK; Tan G; Fellows RE
    Exp Cell Res; 1981 Jun; 133(2):261-71. PubMed ID: 7195340
    [No Abstract]   [Full Text] [Related]  

  • 49. Re: Mechanisms by Which Metformin improves Mortality and Hospital Re-admission in Diabetic Patients With Heart Failure.
    Henry Bell DS
    Endocr Pract; 2017 Mar; 23(3):379. PubMed ID: 28288305
    [No Abstract]   [Full Text] [Related]  

  • 50. Biguanides and the erythrocyte insulin receptor.
    Dons RF
    N Engl J Med; 1982 Jan; 306(2):110-1. PubMed ID: 7053480
    [No Abstract]   [Full Text] [Related]  

  • 51. Obesity, Type 2 diabetes and metformin.
    Arch Dis Child; 2017 Sep; 102(9):869. PubMed ID: 28821495
    [No Abstract]   [Full Text] [Related]  

  • 52. Characterization of Huh7 cells after the induction of insulin resistance and post-treatment with metformin.
    Villalva-Pérez JM; Ramírez-Vargas MA; Serafín-Fabían JI; Ramírez M; Elena Moreno-Godínez M; Espinoza-Rojo M; Flores-Alfaro E
    Cytotechnology; 2020 Aug; 72(4):499-511. PubMed ID: 32409919
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
    Salpeter SR; Greyber E; Pasternak GA; Salpeter EE
    Cochrane Database Syst Rev; 2010 Apr; 2010(4):CD002967. PubMed ID: 20393934
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Value of biguanide in therapy of diabetes mellitus].
    Haupt E; Panten U
    Med Klin (Munich); 1997 Aug; 92(8):472-9, 505. PubMed ID: 9340472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of non-insulin-dependent diabetes mellitus and its complications. A state of the art review.
    Ilarde A; Tuck M
    Drugs Aging; 1994 Jun; 4(6):470-91. PubMed ID: 8075474
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Captopril-induced acute renal artery thrombosis and persistent anuria in a patient with documented pre-existing renal artery stenosis and renal failure.
    Williams PS; Hendy MS; Ackrill P
    Postgrad Med J; 1984 Aug; 60(706):561-3. PubMed ID: 6382225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of metformin on hepatocyte insulin receptor binding in normal, streptozotocin diabetic and genetically obese diabetic (ob/ob) mice.
    Lord JM; Atkins TW; Bailey CJ
    Diabetologia; 1983 Aug; 25(2):108-13. PubMed ID: 6354812
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic traditions in Northern Ireland, Norway and Sweden: I. Diabetes. WHO Drug Utilization Research Group (DURG).
    Griffiths K; McDevitt DG; Andrew M; Baksaas I; Helgeland A; Jervell J; Lunde PK; Oydvin K; Agenäs I; Bergman U
    Eur J Clin Pharmacol; 1986; 30(5):513-9. PubMed ID: 3530780
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metformin enhances certain insulin actions in cultured rat hepatoma cells.
    Purrello F; Gullo D; Buscema M; Pezzino V; Vigneri R; Goldfine ID
    Diabetologia; 1988 Jun; 31(6):385-9. PubMed ID: 2901378
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update.
    Marchetti P; Navalesi R
    Clin Pharmacokinet; 1989 Feb; 16(2):100-28. PubMed ID: 2656043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.